Our results show decreased Gd-DTPA uptake and decreased Ktrans value in tumors treated with Hrnr siRNA, suggesting that hornerin knockdown results in both structural and functional vascular changes that lead to decreased tumor growth. This evidence concerns the gene HRNR and neoplasm.